The Wnt1 Overexpression TCF/LEF Luciferase Reporter HEK293 Stable Cell Line is a dual-functional cell model that stably expresses human Wnt1 together with a TCF/LEF-responsive firefly luciferase reporter, enabling autonomous activation and quantitative measurement of the canonical Wnt/β-catenin signaling pathway within the same cell.
This stable cell line is ideally suited for screening Wnt pathway agonists and antagonists, evaluating compounds that modulate β-catenin signaling, and investigating the mechanisms of Wnt-dependent transcription. The integrated Wnt1 expression eliminates the need for exogenous recombinant Wnt proteins or co-culture with Wnt-producing cells, providing a robust, reproducible, and streamlined assay platform for drug discovery and pathway analysis.
Wnt1, a canonical Wnt ligand, binds to the Frizzled (FZD) receptor and LRP5/6 co-receptor, leading to inhibition of the β-catenin destruction complex. Consequently, β-catenin accumulates in the cytoplasm and translocates into the nucleus, where it associates with TCF/LEF transcription factors to drive the expression of Wnt-responsive genes. In this stable cell line, pathway activation is quantitatively measured through luciferase expression under the control of TCF/LEF response elements, providing a sensitive, reliable, and reproducible readout of canonical Wnt signaling activity.
Applications
- Screening of Wnt/β-catenin pathway inhibitors and activators
- Evaluation of compounds targeting Wnt1 ligand secretion, Frizzled/LRP5/6 receptors, GSK3β, Axin, APC, β-catenin, or TCF/LEF-mediated transcription
- Functional analysis of canonical Wnt1 signaling
- High-throughput drug discovery and pathway validation
Features
- Stable co-expression of human Wnt1 and TCF/LEF luciferase reporter
- Autonomous activation of canonical Wnt/β-catenin signaling
- Quantitative luciferase readout of TCF/LEF transcriptional activity
- Eliminates the need for recombinant Wnt1 proteins or Wnt1-producing feeder cells
- Robust, reproducible, and high-throughput compatible assay platform
- Suitable for compound screening and mechanistic studies of the Wnt signaling pathway
